GNLX Genelux Corp.: Multiplikator nilai perusahaan marang pendapatan

Genelux Corp. (GNLX) - logo korporat

Genelux Corporation is implementing ESG principles by minimizing hazardous waste in biotech. The change in the enterprise value-to-revenue multiple on the GURU.Markets chart confirms that the 10147000.00 mark serves as a key metric. While the scientific authority of GNLX in viral therapy earns the trust of physicians, liquidity shortages and high trial costs are creating significant financial pressure.

Genelux - Rasio nilai perusahaan marang pendapatan GNLX (periode 23.11.2025 - 20.11.2026)

genelux.com - rincian analitis lan metrik utama (GNLX)

- kuotasi lan prakiraan analis:
- indikator dhuwit lan arus kas:
Pambiji fundamental perusahaan:GNLX, Genelux Corp
Produk asli Genelux Corporation

This indicator reflects the ratio of total enterprise value to annual sales, excluding the impact of leverage. Analyzing the EV/Sales multiple allows investors to filter out market noise and assess the real value of assets relative to revenue generation. This chart's price action signals the degree of the asset's overbought status within the current trend. For Genelux Corporation (GNLX), this metric is critical due to high R&D expenditures. The scalability of the oncolytic platform should reduce this coefficient over time through therapy diversification.